Darzalex (daratumumab) is a targeted immunotherapy drug used to treat multiple myeloma, a type of blood cancer. It works by attaching to CD38 proteins on cancer cells, helping the immune system destroy them. Administered via intravenous infusion or subcutaneous injection, it benefits adults newly diagnosed or with relapsed/refractory multiple myeloma, often combined with other therapies.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends